Drug prices for commercial health plans could increase under the recently passed Inflation Reduction Act. HR must act now to reduce costs. Read our CEO Chris Blackley’s commentary on these changes in BenefitsPRO.
In a recent Drug Topics live interview at NCPDP 2025, Prescryptive’s SVP of Provider Solutions, Miranda Rochol, shares…
Miranda Rochol, Senior Vice President at Prescryptive Health, is leading the charge in transforming how healthcare consumers interact…
Prescryptive has been honored with the prestigious MedTech Breakthrough Award for Best Pharmacy Benefits Solution in 2025. This…